U
UPMC Enterprises, the venture capital arm of UPMC, focuses its investments on translational sciences, digital solutions, information technology, and the broader healthcare sector, including medical devices and life sciences ventures. Their strategy involves a flexible investment model, partnering with early- to growth-stage companies that offer innovative and disruptive solutions to improve patient care, while also aiming for significant financial returns.
100% of their portfolio is in Healthcare. Their most common stage is series-e (100% of deals).
Portfolio
1
Fund Size
$1B
Top Stage
Series E
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Portfolio
1 investment
| Company | Round | Amount | Date |
|---|---|---|---|
 Health Catalyst | Series E | $70M | Feb 2016 |
Top Co-Investors
Norwest Venture Partners1 shared
Sequoia Capital1 shared
HV Capital1 shared
MultiCare Health System1 shared
OSF HealthCare1 shared
Sands Capital1 shared
Kaiser Permanente Ventures1 shared
Leavitt Equity Partners1 shared
Tenaya Capital1 shared
Last updated: 28 April 2026